These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8551473)

  • 1. Conservative management of ovarian hyperstimulation syndrome.
    Morris RS; Miller C; Jacobs L; Miller K
    J Reprod Med; 1995 Oct; 40(10):711-4. PubMed ID: 8551473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ovarian hyperstimulation syndrome.
    Aboulghar M
    Semin Reprod Med; 2010 Nov; 28(6):532-9. PubMed ID: 21082512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of ovarian hyperstimulation syndrome: its relation to number of conceptuses.
    Koike T; Minakami H; Araki S; Sayama M; Matsubara S; Suzuki M
    Int J Fertil Womens Med; 2004; 49(1):36-42. PubMed ID: 15038508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.
    Barak V; Elchalal U; Edelstein M; Kalickman I; Lewin A; Abramov Y
    Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
    Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
    Smith LP; Hacker MR; Alper MM
    Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal human chorionic gonadotropin levels and normal pregnancy outcomes in the ovarian hyperstimulation syndrome.
    Samuel MJ; Grosskinsky CM
    J Reprod Med; 2004 Jan; 49(1):8-12. PubMed ID: 14976788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
    Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and obstetric outcome of ovarian hyperstimulation syndrome.
    Zareen N
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):86-90. PubMed ID: 18454892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation.
    Zamah AM; El-Sayed YY; Milki AA
    Fertil Steril; 2008 Oct; 90(4):1202.e7-10. PubMed ID: 18929050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study.
    Casals G; Fábregues F; Pavesi M; Arroyo V; Balasch J
    Acta Obstet Gynecol Scand; 2013 Jun; 92(6):686-91. PubMed ID: 23451918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
    Zhu YM; Gao HJ; He RH; Huang HF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
    Mocanu E; Redmond ML; Hennelly B; Collins C; Harrison R
    Hum Fertil (Camb); 2007 Sep; 10(3):175-81. PubMed ID: 17786650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment.
    Ayustawati ; Shibahara H; Hirano Y; Suzuki T; Takamizawa S; Suzuki M
    Fertil Steril; 2004 Sep; 82(3):579-85. PubMed ID: 15374699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 is high in the serum of IVF pregnancies with ovarian hyperstimulation syndrome.
    Gutman G; Soussan-Gutman L; Malcov M; Lessing JB; Amit A; Azem F
    Am J Reprod Immunol; 2004 May; 51(5):381-4. PubMed ID: 15212675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.